Skip to main content
. 2017 Apr 27;313(2):L350–L359. doi: 10.1152/ajplung.00038.2017

Fig. 2.

Fig. 2.

RVSP of WT mice (n = 9) and WT mice treated chronically with t-TUCB (n = 7), a sEH inhibitor, under control conditions and exposure of mice to hypoxia in the absence and presence of 14,15-EEZE respectively. *Significant difference from their controls, P < 0.05. #Significant difference from WT mice under hypoxia, P < 0.05. @Significant difference from sEH-KO mice under hypoxia, P < 0.05.